Professor Dorothy Keefe, PSM MBBS, MSc, MA, MD, FRACP, FRCP(Lon)
Professor Dorothy Keefe is the CEO of Cancer Australia, Australia’s national cancer agency. She is a medical oncologist and supportive care expert, with an interest in reducing inequity in cancer outcomes. Her major work at Cancer Australia has been in development of the lung cancer screening program, which commences on 1 July, and the Australian Cancer Plan, which is now 18 months into implementation. Dorothy has represented Australia on the Governing Council of IARC since 2020, and as the Australian representative has been elected Chair.
Claire Howlett
Claire Howlett is the Deputy CEO of Cancer Australia. Claire has advised government on issues ranging from biodiversity policy to energy efficiency, and healthcare.
Prior to joining Cancer Australia, Claire led cancer policy advice for the Australian Government Department of Health, Disability and Ageing, including delivering the three national cancer screening programs. Prior to that, she was responsible for delivering government services to the Indian Ocean Territories of Christmas and the Cocos (Keeling) Islands, which included overseeing one of Australia’s most remote health services.
Claire provides strategic leadership and direction to the agency, including throughout the development of the Australian Cancer Plan.
Head, Clinical Policy Advice Branch
Professor Vivienne Milch, MBBS (Hons), MHPol
Professor Vivienne Milch is Medical Director, at Cancer Australia. Professor Milch is also Medical Advisor to the Australian Commonwealth Department of Health, Disability and Ageing on cancer screening policy, holds a Master’s degree in Health Policy and is an Adjunct Clinical Associate Professor in the School of Medicine, Sydney Campus at The University of Notre Dame, Australia and Professorial Fellow at the Caring Futures Institute at Flinders University in Adelaide.
Prior to joining Cancer Australia, Professor Milch was a General Practitioner and clinical researcher at the Garvan Institute of Medical Research, Sydney.
In her current role, Professor Milch provides strategic clinical policy leadership to Cancer Australia’s work to minimise the impact of cancer, address disparities, and improve the health outcomes of people affected by cancer in Australia.
David Meredyth
David Meredyth is the Head of the Cancer Control Strategy Branch at Cancer Australia.
An experienced senior executive with a background in health policy, cancer control, and public administration, David has held leadership roles across the Australian Public Service, including more than 20 years at the Department of Health, Disability and Ageing, working in health workforce education as well as cancer policy and programs.
At Cancer Australia, David is responsible for leading the agency’s cancer control strategy, including the development and implementation of national cancer control policies and programs. He oversees various initiatives particularly overseeing First Nations Cancer Outcomes measures.
& Communications Branch
Adam Lambert
Adam Lambert, Head of the Evidence, Priority Initiatives & Communications Branch, leads initiatives aligned with the Australian Cancer Plan to improve cancer outcomes. His role includes collaborating with the cancer sector, enhancing national cancer data, managing strategic communications and driving preparations for the National Lung Cancer Screening Program.
With diverse experience, Adam has more than 25 years experience in the Australian Public Service, including leadership roles across health emergency management and the national responses to the COVID-19 pandemic and Black Summer bushfires, international emergency medical deployments, global leaders summits, major sporting events, national security coordination and central government.
& Chief Operations Officer
Elmer Wiegold
Elmer Wiegold is the COO/CFO and Head of the Corporate Operations Branch at Cancer Australia. Elmer is a qualified Chartered Accountant who began his public sector career as an accountant working in South Australia. He has held senior executive roles in strategy, finance, corporate affairs and program and project delivery in the public sector.
Elmer also has substantial experience in finance, human resources, and corporate services, having worked as a CFO and general manager of corporate affairs for several federal government entities.
His responsibilities include Cancer Australia’s corporate governance arrangements, financial performance, management of human resources, ministerial and parliamentary coordination, compliance, and other accountability obligations.
